DANIEL CHANG: Open Payments
NPI 1871315242 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$996 in 42 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $289 · 2025 $996
Food & beverage: $996
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 7 | $162 |
| Endo USA, Inc. | 9 | $141 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $136 |
| Dendreon Pharmaceuticals LLC | 4 | $118 |
| Janssen Biotech, Inc. | 4 | $102 |
| Merck Sharp & Dohme LLC | 3 | $97 |
| TOLMAR, INC. | 2 | $60 |
| Ferring Pharmaceuticals Inc. | 3 | $50 |
| Boston Scientific Corporation | 2 | $40 |
| Telix Pharmaceuticals | 1 | $24 |
Products named: GEMTESA, Nubeqa, AVEED, PROVENGE, ERLEADA, KEYTRUDA, ADSTILADRIN, General - Erectile Dysfunction.
Industry payments across NC — which companies pay providers there.
